The importance of patient centricity and getting new treatments to market efficiently and safely have been core drivers for innovative trial designs, ways to conduct assessments, and how to lessen the burden of the site, patient, caregiver, and clinical trial personnel. While there are many topics we can discuss, we will be focusing on Centralized Clinical Trials. Recent events have proven the need for all of us to be flexible and to give us that push to adapt these innovative processes into practice. In this webinar we’ll discuss how the emerging “new normal” will impact Centralized Clinical Trial activity.
Quan Doan, Director, Technology Solutions at SDC and Carrie Hamilton, Director, Clinical Science at Stiris Research Inc. will explore definitions of Centralized Clinical Trial Activities, previous successes, potential challenges to come, and ways to develop clinical trials to maximize these centralized monitoring activities.